Affinity Capital Advisors’s Astera Labs ALAB Stock Holding History

Affinity Capital Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Buy	+762	New	+$202K	0.04%	136

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Tensor Edge Capital Weston, Massachusetts $1.51B AUM

M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Global X Japan Chiyoda-Ku, Tokyo, Japan $2.72B AUM 45.88% 1-Year Est. Return

Integrated Financial Solutions Reston, Virginia $185M AUM 67.6% 1-Year Est. Return

Affinity Capital Advisors's ALAB Position: Q2 2026 in Review

Affinity Capital Advisors opened a new position in Astera Labs (ALAB) in Q2 2026: 762 shares worth $330K. The stake represents 0.04% of the portfolio and ranks #136 among its holdings.

107 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Affinity Capital Advisors held 762 shares of Astera Labs worth $330K as of Q2 2026.
Astera Labs was a new Affinity Capital Advisors position in Q2 2026.
Astera Labs made up 0.04% of Affinity Capital Advisors's portfolio in Q2 2026, its #136 holding.
107 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.